Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.
Press releases published on July 9, 2025

Pillar Security Uncovers Novel Attack Vector That Embeds Malicious Backdoors in Model Files on Hugging Face
TEL EVIV, Israel, July 09, 2025 (GLOBE NEWSWIRE) -- Pillar Security, a leading company in AI security, discovered a novel supply chain attack vector that targets the AI inference pipeline. This novel technique, termed "Poisoned GGUF Templates," allows …

Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036
SOLANA BEACH, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today …

Foresight: Eye-Net, in Collaboration with Orange’s Mobile Application, Achieves 99% Detection Rate in French Urban Mobility Trials
Eye-Net’s V2X collision prevention technology is scheduled for live trial with 10,000 participants in the fourth quarter of 2025 Ness Ziona, Israel, July 09, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” …

Marlon Williams Joins Alpha Liquid Terminal as Advisor, Expanding Reach into AI-Powered Trading and Inclusive Web3 Innovation
New York, NY, July 09, 2025 (GLOBE NEWSWIRE) -- Alpha Liquid Terminal (ALTx), the next-generation modular trading and analytics platform for tokenized finance, is proud to announce that Marlon Williams, serial Web3 entrepreneur and founder of AIQuant.fun …

MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025
ROCKVILLE, Md., July 09, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell …

New Clinical Findings Published in Scientific Journal Nature Validate LIXTE’s Ongoing Ovarian and Colorectal Cancer Trials
Article Indicates that Inhibition of PP2A Enhances Immunotherapy Response with LIXTE’s Proprietary Compound LB100 PASADENA, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a …

Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution
NEEDHAM, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

Strong Leach Recoveries and Low Impurities Drive Halleck Creek Closer to Unlocking Its Rare Earth Potential
Highlights High Light Rare Earths Leach Recoveries Praseodymium (“Pr”) leach recoveries of 85% at optimal conditions Neodymium (“Nd”) leach recoveries of 84% at optimal conditions Encouraging Heavy Rare Earths Leach Recoveries Terbium (“Tb”) leach …

TTM Technologies, Inc. Prepares For the Future with the Acquisition of a Facility in Wisconsin and Land in Penang
SANTA ANA, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI), a leading global manufacturer of technology solutions including mission systems, radio frequency (“RF”) components and RF microwave/microelectronic assemblies, …

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025
PORTLAND, Maine, July 09, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …

KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
-- Topline results from the CHASE trial expected by end of Q3 2025 -- -- Potential for CHASE to serve as a pivotal trial in support of a Biologics License Application (BLA) submission, contingent on positive results -- ARLINGTON, Mass., July 09, 2025 ( …

Novenda Technologies secures $6.1M to revolutionize dental products with breakthrough 3D printing
Eindhoven, July 09, 2025 (GLOBE NEWSWIRE) -- As sugar consumption rises and dental visits become increasingly expensive, nearly 3.5 billion people worldwide struggle with oral diseases. The dental industry faces mounting pressure to increase manufacturing …

BioVie Announces Data Highlighting Bezisterim’s Potential to Slow or Reverse Biological Aging and Neurodegeneration Featured as a Keynote Talk at the 7th World Aging and Rejuvenation Conference
CARSON CITY, Nev., July 09, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver …

FluidForm Bio™ Presents Six-Month Efficacy Data of FRESH 3D Bioprinted Human Islet Subcutaneous Scaffolds at the American Diabetes Association (ADA) 85th Scientific Sessions
WALTHAM, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced two presentations at recent medical meetings: the 20th World Congress of the International Pancreas …

zSpace Imagine Wins Future’s Best of Show Award at ISTELive25, Presented by Tech & Learning
SAN JOSE, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- zSpace (NASDAQ: ZSPC) (“zSpace” or the “Company”), a leader in immersive learning, announced today that the Company is a recipient of Future’s Best of Show Award, presented at ISTE 2025 by Tech …

‘Lavender & The Butterfly Nation’ Pushes Boundaries with World’s First GenAI-Hybrid Animated Feature
LONDON, July 09, 2025 (GLOBE NEWSWIRE) -- IMAGENai Inc., a boundary-pushing GenAI creative studio, unveils its pioneering animated feature, Lavender …

NFI subsidiary New Flyer receives significant order from Ottawa-Carleton’s OC Transpo for 124 Xcelsior Charge NG™ buses
WINNIPEG, Manitoba, July 09, 2025 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI) a leader in propulsion-agnostic bus and coach mobility solutions, subsidiary New Flyer Industries Canada ULC (New Flyer), today announced a …

TerrAscend Completes $79 Million Non-Dilutive Debt Financing
Proceeds used to retire $68 million of existing debt with the remainder designated for future growth initiatives Additional facility of up to $35 million available for strategic M…

Amneal to Report Second Quarter 2025 Results on August 5, 2025
BRIDGEWATER, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that the Company will release its second quarter 2025 financial results on …

Introducing Aptean Fresh Produce ERP: The Next-Generation of Produce Pro Software
Unifying Decades of Fresh Produce Expertise with Cutting-Edge Technology in a Powerful, Cloud-Based ERP Solution ALPHARETTA, Ga., July 09, 2025 (GLOBE NEWSWIRE) -- Aptean, a global leader in mission-critical enterprise software solutions, announces the …